{"title":"评论:不报销胰岛移植造成了对1型糖尿病患者的歧视。","authors":"T Berney","doi":"10.32113/cellr4_201910_2774","DOIUrl":null,"url":null,"abstract":"<p><p>In this commentary reviewing the activity of the University of Geneva islet transplantation program, the author argues that health care coverage of the procedure will stop discrimination against a subset of patients with type 1 diabetes in need of beta-cell replacement but unfit to receive a whole pancreas transplant.</p>","PeriodicalId":87230,"journal":{"name":"CellR4-- repair, replacement, regeneration, & reprogramming","volume":"7 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439342/pdf/nihms-1057562.pdf","citationCount":"0","resultStr":"{\"title\":\"Commentary: Not reimbursing islet transplantation creates discrimination against patients with type 1 diabetes.\",\"authors\":\"T Berney\",\"doi\":\"10.32113/cellr4_201910_2774\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In this commentary reviewing the activity of the University of Geneva islet transplantation program, the author argues that health care coverage of the procedure will stop discrimination against a subset of patients with type 1 diabetes in need of beta-cell replacement but unfit to receive a whole pancreas transplant.</p>\",\"PeriodicalId\":87230,\"journal\":{\"name\":\"CellR4-- repair, replacement, regeneration, & reprogramming\",\"volume\":\"7 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439342/pdf/nihms-1057562.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CellR4-- repair, replacement, regeneration, & reprogramming\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32113/cellr4_201910_2774\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2019/10/31 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CellR4-- repair, replacement, regeneration, & reprogramming","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32113/cellr4_201910_2774","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/10/31 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Commentary: Not reimbursing islet transplantation creates discrimination against patients with type 1 diabetes.
In this commentary reviewing the activity of the University of Geneva islet transplantation program, the author argues that health care coverage of the procedure will stop discrimination against a subset of patients with type 1 diabetes in need of beta-cell replacement but unfit to receive a whole pancreas transplant.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
